
    Original Text: Agrees to continue use of approved birth control for at least 6 months after receiving the last dose of study drugs
    Disease/Condition: None
    Procedure: None
    Drug: None
    Biomarker: None
    Computable Rule: Agrees to continue use of approved birth control for at least 6 months after receiving the last dose of study drugs

Criterion:
    Patients with metastatic colorectal cancer who have received prior treatment with oxaliplatin, irinotecan, fluoropyrimidine, and anti-VEGF therapy

Output:
    Original Text: Patients with metastatic colorectal cancer who have received prior treatment with oxaliplatin, irinotecan, fluoropyrimidine, and anti-VEGF therapy
    Disease/Condition: Metastatic Colorectal Cancer
    Procedure: None
    Drug: None
    Biomarker: None
    Computable Rule: Disease is "Metastatic Colorectal Cancer" AND Prior Treatment